Current status of domestic therapeutic radiopharmaceuticals

Release time：

Aug 30,2022

In the past, radiopharmaceuticals were often used in the diagnosis of lesions an≠d in the instrumental examination of PET-CT and SPECT. Radiopharmaceuticals are s ynthesized by labeling with radionuclides to target compounds. In diagnostic use, patients nδeed to record their positions and changes in the body through an in vitro monitoring gaδmma ray device after taking radiopharmaceuticals to understand the lesions. The t¶herapeutic radiopharmaceuticals have the same function of locating th&e lesions. After the radionuclide-labeled drugs are specifically bound to the lesions, they πcan use radioactivity to continuously kill the surrounding cells.

Radiopharmaceuticals refer to a class of special drugs containing radionuclides for medical diagn₩osis and treatment. A radionuclide-labeled compound or biological agent used for medical diagnosis λor treatment in the body. Divided into diagnostic radiopharmaceuticals and therapeutic radiopha₩rmaceuticals.

In the past, radiopharmaceuticals were often used in the diagnosis of lesions and in the instrume₽ntal examination of PET-CT and SPECT. Radiopharmaceutic↓als are synthesized by labeling with radionuclides to target compounds. In diag✘nostic use, patients need to record their positions and changes in the body§ through an in vitro monitoring gamma ray device after taking radiopharmaceuticals to♠ understand the lesions. The therapeutic radiopharmaceu♠ticals have the same function of locating the lesions. After the radionuclide-l♥abeled drugs are specifically bound to the lesions, th‍ey can use radioactivity to continuously kill the surrounding cells.<

In recent years, the state has encouraged the development of the medical isotγope industry. In addition to the use of diagnostic radiopharmaceuticals, th&erapeutic radiopharmaceuticals have been slowly developed. Among the drugs on the market iβn China, a total of 7 drugs belong to this category, among which radium  chloride [223Ra] injection and yttrium [90Y] microspher'e injection are only imported drugs.

The market situation of therapeutic radiopharmaceuticals∏

The global sales of therapeutic radiopharmaceuticals co±ntinued to grow, especially in 2020, reaching US$1.79 billion, with≥ a compound growth rate of 14.9% from 2016 to 2020. ; Sales p©eaked in 2019, with a total of 566,000 doses sold, a CAGR of¶ 14%.

Copyright © 2022 Anhui Union Pharmaceuticals Technology Co., Ltd.